Articles

Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA, 55902; Division of Hematology, Mayo Clinic, Rochester, MN, USA, 55905
Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA, 14642
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA, 55902
Division of Hematology, Mayo Clinic, Rochester, MN, USA, 55905
Department of Medicine, Comprehensive Sylvester Cancer Center, University of Miami, Miami, FL, USA, 33124
Division of Hematology, Mayo Clinic, Rochester, MN, USA, 55905
University of Texas, MD Anderson Cancer Center, Houston, TX, USA, 77030
Department of Medicine, University of Iowa, Iowa City, IA, USA, 52242
University of Texas, MD Anderson Cancer Center, Houston, TX, USA, 77030
Department of Medicine, Weill Cornell Medical College, New York, NY, USA, 10075
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA, 30322
Department of Medicine, Washington University in St Louis, St Louis, MO, USA, 63130
Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA, 14642
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA, 30322
Genentech, Inc., South San Francisco, CA, USA, 94080
Genentech, Inc., South San Francisco, CA, USA, 94080
Genentech, Inc., South San Francisco, CA, USA, 94080
Genentech, Inc., South San Francisco, CA, USA, 94080
Genentech, Inc., South San Francisco, CA, USA, 94080
Genentech, Inc., South San Francisco, CA, USA, 94080
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA, 55902
Department of Medicine, University of Iowa, Iowa City, IA, USA, 52242
University of Texas, MD Anderson Cancer Center, Houston, TX, USA, 77030
Vol. 109 No. 7 (2024): July, 2024 https://doi.org/10.3324/haematol.2023.283737